These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 465352)

  • 21. Erythrocyte PK deficiency: biochemical characterization of a patient with haemolytic anemia.
    González R; Estrada M; Garcia M; Gutiérrez A; de la Torre E; Colombo B
    Haematologia (Budap); 1987; 20(1):51-5. PubMed ID: 3596364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].
    Boivin P; Galand C
    Pathol Biol (Paris); 1977 Mar; 25(3):161-7. PubMed ID: 323784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
    Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
    Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
    Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
    Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic study of the age-related loss of activity of six enzymes in the red cells from newborn infants and adults--evidence for a fetal type of erythrocyte phosphofructokinase.
    Kahn A; Boyer C; Cottreau D; Marie J; Boivin P
    Pediatr Res; 1977 Apr; 11(4):271-6. PubMed ID: 139592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of exogenous adenine in a pyruvate kinase-deficient patient.
    Lappin TR; Elder GE; Savage GA; Bridges JM
    Scand J Clin Lab Invest; 1983 Apr; 43(2):111-8. PubMed ID: 6612220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inherited hemolytic anemia due to pyruvate kinase deficiency: II. Density-layer centrifugation of erythrocytes (author's transl)].
    Goebel KM; von Manteuffel G; Hausmann L; Kaffarnik H
    Med Klin; 1979 May; 74(18):691-4. PubMed ID: 285328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normalisation of red blood cell pyruvate kinase in pyruvate kinase deficiency by riboflavin treatment.
    Staal GE; van Berkel TJ; Nijessen JG; Koster JF
    Clin Chim Acta; 1975 May; 60(3):323-7. PubMed ID: 1139778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythrocyte pyruvate kinase deficiency: 11 new cases.
    Zanella A; Colombo MB; Miniero R; Perroni L; Meloni T; Sirchia G
    Br J Haematol; 1988 Jul; 69(3):399-404. PubMed ID: 3408673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Energy metabolism of erythrocytes in pyruvate kinase enzymopathies].
    Jacobasch G; Grieger M; Gerth C; Bier K
    Acta Biol Med Ger; 1977; 36(5-6):717-30. PubMed ID: 602578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical heterogeneity of erythrocyte pyruvate kinase deficiency. Evidence of an impaired utilization of ATP in a clinically severe form.
    Schröter W
    Helv Paediatr Acta; 1972 Nov; 27(5):471-88. PubMed ID: 4640902
    [No Abstract]   [Full Text] [Related]  

  • 33. Congenital non-spherocytic haemolytic anaemia variants with primary and secondary pyruvate kinase deficiency. II. Enzymatic studies.
    Gumińska M; Wazewska-Czyzewska M
    Br J Haematol; 1979 Jan; 41(1):125-32. PubMed ID: 154343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency.
    Richard RE; Weinreich M; Chang KH; Ieremia J; Stevenson MM; Blau CA
    Blood; 2004 Jun; 103(12):4432-9. PubMed ID: 14988153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular abnormality of erythrocyte pyruvate kinase deficiency in the Amish.
    Kanno H; Ballas SK; Miwa S; Fujii H; Bowman HS
    Blood; 1994 Apr; 83(8):2311-6. PubMed ID: 8161798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental changes of mouse red cell pyruvate kinase.
    Gilman JG; Jenkins GM
    Biomed Biochim Acta; 1983; 42(11-12):S273-7. PubMed ID: 6675702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary pyruvate kinase deficiency: role of the abnormal enzyme in red cell pathophysiology.
    Zanella A; Rebulla P; Vullo C; Izzo C; Tedesco F; Sirchia G
    Br J Haematol; 1978 Dec; 40(4):551-62. PubMed ID: 728372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and molecular characterization of variant pyruvate kinase enzymes and genes from three patients with red blood cell pyruvate kinase deficiency.
    Johnson ML; Jones DP; Freeman JM; Wang W
    Acta Haematol; 1991; 86(2):79-85. PubMed ID: 1683086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired pyruvate kinase deficiency.
    Morse EE; Jilani F; Brassel J
    Ann Clin Lab Sci; 1977; 7(5):399-404. PubMed ID: 900864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical modelling of metabolic pathways affected by an enzyme deficiency. A mathematical model of glycolysis in normal and pyruvate-kinase-deficient red blood cells.
    Holzhütter HG; Jacobasch G; Bisdorff A
    Eur J Biochem; 1985 May; 149(1):101-11. PubMed ID: 3996397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.